SB2

etanercept biosimilar · Samsung Bioepis Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SB2, covering 2016-08-29 to 2019-02-21. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB2 in Healthy Subjects [Phase 1]